Old Web
English
Sign In
Acemap
>
authorDetail
>
Camille Catherine Jackson
Camille Catherine Jackson
University of Oklahoma Health Sciences Center
Medicine
Oncology
Internal medicine
Endometrial cancer
Bevacizumab
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors—Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort.
2021
Journal of Clinical Oncology
Erika Hamilton
Camille Catherine Jackson
Ramez N. Eskander
Floor Jenniskens Backes
Vicky Makker
Fernanda Musa
Alexander B. Olawaiye
Jill Alldredge
Bhavana Pothuri
Angeles Alvarez Secord
Nicole Concin
Antonio González-Martín
Jowell Go
Kenton Wride
Denise M. Lepley
T. Cameron
Manish R. Patel
Show All
Source
Cite
Save
Citations (0)
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
2021
Journal of Clinical Oncology
Camille Catherine Jackson
Leigh A. Cantrell
Britt K. Erickson
Kathleen N. Moore
Linda R. Duska
Debra L. Richardson
Lisa M. Landrum
Laura L. Holman
Joan L. Walker
Robert S. Mannel
Katherine M. Moxley
Lurdes Queimado
Kai Ding
Andrew J. Cohoon
Sara K. Vesely
L.E. Dockery
Show All
Source
Cite
Save
Citations (0)
1